Bench Top Flow Cytometry Workshop and Leukaemia Workshop

Location:

University of Newcastle upon Tyne

Date:

09 July 2007 - 12 July 2007

Contact:

Lynsey Fenwick

Tel:

0191 222 6279

Fax:

Email:

l.d.fenwick@ncl.ac.uk

Website:

Event Programme

Bench Top Flow Cytometry Workshop 
9 - 11 July 2007 
Over the past 20 years there have been Bench Top Clinical Flow Cytometry Workshops organised in Newcastle to help both new and "experienced" users in aspects of practical flow cytometry. Presentations will cover the major new developments in flow cytometry in areas of Haematology, Immunology, Microbiology and Blood Transfusion. It is planned that, as in previous meetings, active participation by commercial sponsors will occur. 
 
Topics included will be: 
Whats new in Flow Cytometry 
Applications in Immunology, Leukaemia Diagnosis, Haematology, Microbiology and Blood Transfusion 
Cell function Studies 
Stem Cell Enumeration 
Applications of Multicolour Flow Cytometry 
Luminex/Multiplex 
Specific Problems in Flow Cytometry 
Bench Top Sorter? 
Stem Cells 
The main aim of the workshop is for individuals to raise problems they have encountered. 
 
Over the past couple of years, a large number of multiplex reagents and kits have been produced. Many kits have specific applications for typing antibody specifities, for genotyping and for measuring multiple proteins simultaneously. 
A session is planned to provide a review of multiples technology using a range of detector systems - flow cytometry, luminex technology and CCD camera technology. 
 
Leukaemia Focus Workshop 
11 - 12 July 2007 
This workshop has been devised to focus primarily on the immunophenotyping of leukaemias by flow cytometry. It is aimed both at laboratory biomedical scientists and clinical registrars who are new or have some experience of the field and would like to extend their knowledge. 
The key areas to be discussed will address some of the exciting new developments in this field and the challenges they present to a routine diagnostic laboratory and their influence to the clinicians. 
New instrumentation, multicolour flow cytometry (how far do we go?), minimal residual disease, prognostic markers, the WHO classification of tumours of haematopoietic and lymphoid tissues, UK Neqas and standardisation. 
The intention of this Leukaemia Focus session is to discuss openly how to deal with these challenges in a clinical context.